Regencell Bioscience Lim...

NASDAQ: RGC · Real-Time Price · USD
12.91
0.21 (1.65%)
At close: Aug 15, 2025, 3:44 PM

Regencell Bioscience Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-4.36M -6.06M -7.59M -1.35M
Depreciation & Amortization
745.59K 769.69K 604.4K 26.46K
Stock-Based Compensation
449.31K 922.62K 2.76M n/a
Other Working Capital
-585.37K -508.94K -1.02M 552.98K
Other Non-Cash Items
-248K -85.4K -10.73K 52.91K
Deferred Income Tax
n/a 1.42K n/a n/a
Change in Working Capital
-585.37K -508.94K -1.02M 552.98K
Operating Cash Flow
-4M -4.96M -5.27M -767.31K
Capital Expenditures
-5.38K -27.39K -780.88K n/a
Cash Acquisitions
n/a 970.00 n/a n/a
Purchase of Investments
-5M -10M -10M n/a
Sales Maturities Of Investments
10.25M 10.09M n/a n/a
Other Investing Acitivies
n/a 86.37 -10K n/a
Investing Cash Flow
5.24M 58.98K -10.78M n/a
Debt Repayment
n/a n/a n/a 612.06K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
102.28K 134.91K -267.97K -172.31K
Financial Cash Flow
102.28K 134.91K 22.41M 439.75K
Net Cash Flow
1.4M -4.85M 6.36M -327.57K
Free Cash Flow
-4.01M -4.99M -6.05M -767.31K